GO5855: MRFF 2022 Frontier Health and Medical Research Grant Opportunity

This grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects.

The program of research can propose to develop novel health technologies and/or re-purpose existing health technologies in a novel way.

The process to get funding has 2 stages: expression of interest – outlining a proposed program of research with a 10-year time horizon full application, for a project of up to 5 years under the program of research.

Full applications may be submitted by invitation only.

Applicants may propose to start research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years.

Funding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI).

These applications may be submitted by invitation only.

We expect that expressions of interest will close on 31 March 2026, with the last grants awarded by 30 June 2027.

To be eligible an applicant organisation must have an Australian Business Number (ABN), be incorporated in Australia and, in accordance with section 24 of the MRFF Act, be one of: a medical research institute, a university, a corporate Commonwealth entity, or a corporation (including businesses and not-for-profits).

Joint (consortia) applications are permitted provided there is a Lead Organisation that is eligible to apply.

Applicants must nominate Chief Investigators (up to 15 CIs) and a Chief Investigator A (CIA) as Project Lead; a person may be named as a CI on a maximum of one active expression of interest/full application.

Where invited to submit a full application, the CIA is generally required to be an Australian citizen or permanent resident (or hold the requisite work visa at time of accepting the grant) and must be based in Australia for the duration of the grant.

Applicants must address all eligibility and assessment criteria and comply with formatting, attachment and submission requirements.

Additional documentation (e.g. board/CEO support, partner letters, audited financial statements) is required at full application stage.